1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Multiple Myeloma Progression: new trials by email Literature Review of Multiple Myeloma Progression trials Research Report on Multiple Myeloma Progression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tinostamustine Conditioning and Autologous Stem Cell Tinostamustine, Autologous Stem Cell Transplant (ASCT) - Multiple Myeloma in Relapse, Multiple Myeloma Progression | Phase 1 / Phase 2 | Terminated | Mundipharma-EDO GmbH | 6 | 2018-10-15 | 2021-06-18 |
tinostamustine (1)
Norway (1) · Switzerland (1) · United States (1)
Dagmar Hess (1) · Parameswaran Hari, MD (1)
2018 (1)